Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation
- 1 October 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 82 (1) , 145-150
- https://doi.org/10.1111/j.1365-2249.1990.tb05418.x
Abstract
Some patients undergoing bone marrow transplantation (BMT) persistently present increased proportions of circulating CD57+ T cells. We analysed the cell surface phenotype in peripheral blood mononuclear cells (PBMC) from 69 allogeneic and 11 autologous BMT recipients. In parallel samples from 49 patients, the proliferative response to T cell mitogens was assessed, either in the presence or absence of exogenous interleukin-1 (IL-2). PBMC samples from long-term allogeneic BMT patients with increased proportions of CD57+ cells displayed significantly (P < 0.001) lower proliferative responses, compared with samples from patients with normal proportions of CD57+ cells and from healthy subjects. Elimination of the CD57+ population by C''-dependent lysis did not normalize the proliferative response. After positive selection by cell sorting, CD57+ cells responded poorly, but in the presence of IL-2 the proliferation appeared to be similar to that displayed by the CD57- subset and still suboptimal compared with normal controls. These data suggest that the hyporesponsiveness to mitogenic stimuli in the presence of exogenous IL-2 of PBMC from allogeneic BMT recipients cannot be simply attributed either to the putative suppressor activity of CD57+ cells, or to a poor proliferative capacity of this subset. Supporting this notion we report that PBMC from long-term autologous BMT recipients containing high proportions of CD57+ T cells respond normally to T cell mitogens.Keywords
This publication has 29 references indexed in Scilit:
- Functional analysis of CD8 lymphocytes in long-term surviving patients after bone marrow transplantationJournal of Clinical Immunology, 1988
- The multifactorial etiology of graft-versus-host diseaseImmunology Today, 1987
- Involvement of the CD4 molecule in a post‐activation event on T cell proliferationEuropean Journal of Immunology, 1987
- Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantationEuropean Journal of Immunology, 1987
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Overview of the clinical relevance of autologous bone marrow transplantationClinics in Haematology, 1986
- INCREASED LEU-7-POSITIVE T LYMPHOCYTES DURING CYTOMEGALOVIRUS INFECTION FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIESTransplantation, 1986
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- Improved survival following bone marrow transplantation for aplastic anaemiaBritish Journal of Haematology, 1983
- Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis‐inhibiting effect of 7 monoclonal antibodiesEuropean Journal of Immunology, 1982